|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Accretion income on marketable securities | |||||
| Other non-cash items | |||||
| Other | |||||
| Stock-based compensation expense | |||||
| Gain on disposal of property and equipment | |||||
| Non-cash lease expense | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Maturities of marketable securities | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock from follow-on offering, net of issuance costs | |||||
| Proceeds from issuance of pre-funded warrants from follow-on offering, net of issuance costs | |||||
| Proceeds from issuance of common stock warrants from follow-on offering, net of issuance costs | |||||
| Proceeds from issuance of common stock under ATM facility, net of issuance costs | |||||
| Proceeds from follow-on issuance of common stock | |||||
| Proceeds from ESPP purchases | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Purchases of property and equipment in accounts payable and accrued expenses and other liabilities | |||||
| Initial measurement of right-of-use assets and lease liabilities | |||||
| Disposal of equipment | |||||
Loading...